CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 100 enrolled
Drug / intervention
Korean red ginseng +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01478009
NCT01478009Phase 3Completed
CompareCT.gov

A Placebo-Controlled Trial of Korean Red Ginseng Extract to Prevent Acute Respiratory Illness in Healthy Subjects

Chonbuk National University Hospital·interventional·Posted Nov 23, 2011·Updated Dec 25, 2012

In Brief

A Phase 3 clinical trial evaluating Korean red ginseng and Placebo for Healthy Subjects. Completed, enrolled 100 participants across 1 site.

Detailed Summary

Upper respiratory tract infections are a major source of morbidity throughout the world. Extracts of Korean red ginseng have been found to have the potential to modulate both natural and acquired immune responses. The investigators sought to examine the efficacy of an extract of Korean red ginseng in preventing colds. Therefore, the efficacy and safety of Korean red ginseng will be investigated in healthy subjects during the influenza season.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
CountriesSouth Korea
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 23, 2011
Enrollment StartNov 1, 2010
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.6 years ago

Interventions

Korean red ginsengdietary

Korean red ginseng(3.0g/day) for 12 weeks

Placebodietary

Placebo (3.0g/day) for 12 weeks